ASML Holding N.V. (ASMLF) vs Eli Lilly and Company (LLY)
See how ASML Holding N.V. and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$1,843.38
OTC Markets OTCPK
$1,163.23
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full PageKey Metrics Comparison
ASML Holding N.V.ASMLF
Market Cap$708.042B
Price$1,843.38
24h Change-0.92%
24h Volume$7
Employees43,938
Shares OutstandingN/A
Eli Lilly and CompanyLLY
Market Cap$1.037T
Price$1,163.23
24h Change+1.76%
24h Volume$945.7K
Employees50,000
Shares Outstanding944,818,881
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ASMLF
40.6%LLY
59.4%Volume Share
Share of combined 24h volume
ASMLF
1.0%LLY
100.0%24h Performance
Price change over last 24 hours
ASMLF
-0.92%LLY
1.76%Price Comparison
ASML Holding N.V.
Eli Lilly and Company